Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid Merakris to present encouraging Phase 2 clinical drug trial data at annual Treasure Hunt Podiatry and Wound Conference in Los Angeles, CA, February 24-25.

Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial Merakris Therapeutics announces it has fully enrolled the first part of a clinical trial to evaluate its investigational drug product, Dermacyte® Liquid.

Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis | DelveInsight Las Vegas, USA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Chronic Venous Insufficiency Pipeline: Therapeutic Assessment, Emerging Drugs, Novel Devices, Key Pharma Players, Clinical Trials, and Growth...